The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths
Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths

September 7th 2024

Semaglutide lowers rates of cardiovascular and COVID-19-related deaths in patients with overweight/obesity, offering promising cardio-metabolic and non-cardiovascular benefits.

Brian Callaghan, MD, MS | Credit: Michigan Medicine
Study Finds Diabetes Complications and Mental Health Disorders Are a 2-Way Street

August 27th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Clears Omnipod 5 AID System for Type 2 Diabetes

August 26th 2024

Close up image of a Dexcom Stelo sensor. (Credit: Dexcom Inc.)
Dexcom Announces Availability, Pricing of Stelo—First OTC Glucose Sensor

August 26th 2024

Semaglutide Linked to Suicidal Ideation, New Study Reveals
Semaglutide Linked to Suicidal Ideation, New Study Reveals

August 23rd 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities
© 2024 MJH Life Sciences

All rights reserved.